Barrett Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-185
| Closed | -$44K | – | 254 |
|
|
2021
Q4 | $44K | Buy |
185
+10
| +6% | +$2.57K | ﹤0.01% | 407 |
|
|
2021
Q3 | $50K | Sell |
175
-575
| -77% | -$188K | ﹤0.01% | 317 |
|
|
2021
Q2 | $260K | Sell |
750
-98
| -12% | -$29.7K | 0.01% | 173 |
|
|
2021
Q1 | $237K | Buy |
848
+198
| +30% | +$53.4K | 0.01% | 176 |
|
|
2020
Q4 | $159K | Hold |
650
| – | – | 0.01% | 197 |
|
|
2020
Q3 | $184K | Sell |
650
-50
| -7% | -$13.9K | 0.01% | 169 |
|
|
2020
Q2 | $187K | Buy |
700
+625
| +833% | +$188K | 0.01% | 158 |
|
|
2020
Q1 | $24K | Hold |
75
| – | – | ﹤0.01% | 267 |
|
|
2019
Q4 | $22K | Hold |
75
| – | – | ﹤0.01% | 297 |
|
|
2019
Q3 | $17K | Hold |
75
| – | – | ﹤0.01% | 291 |
|
|
2019
Q2 | $18K | Sell |
75
-29
| -28% | -$6.7K | ﹤0.01% | 290 |
|
|
2019
Q1 | $25K | Hold |
104
| – | – | ﹤0.01% | 279 |
|
|
2018
Q4 | $31K | Hold |
104
| – | – | ﹤0.01% | 261 |
|
|
2018
Q3 | $37K | Hold |
104
| – | – | ﹤0.01% | 262 |
|
|
2018
Q2 | $30K | Hold |
104
| – | – | ﹤0.01% | 277 |
|
|
2018
Q1 | $28K | Hold |
104
| – | – | ﹤0.01% | 283 |
|
|
2017
Q4 | $33K | Hold |
104
| – | – | ﹤0.01% | 279 |
|
|
2017
Q3 | $33K | Hold |
104
| – | – | ﹤0.01% | 264 |
|
|
2017
Q2 | $28K | Hold |
104
| – | – | ﹤0.01% | 276 |
|
|
2017
Q1 | $28K | Hold |
104
| – | – | ﹤0.01% | 260 |
|
|
2016
Q4 | $29K | Hold |
104
| – | – | ﹤0.01% | 261 |
|
|
2016
Q3 | $33K | Hold |
104
| – | – | ﹤0.01% | 239 |
|
|
2016
Q2 | $25K | Hold |
104
| – | – | ﹤0.01% | 244 |
|
|
2016
Q1 | $27K | Hold |
104
| – | – | ﹤0.01% | 241 |
|
|
2015
Q4 | $32K | Sell |
104
-30
| -22% | -$8.62K | ﹤0.01% | 226 |
|
|
2015
Q3 | $39K | Buy |
134
+30
| +29% | +$9.91K | ﹤0.01% | 217 |
|
|
2015
Q2 | $42K | Hold |
104
| – | – | ﹤0.01% | 219 |
|
|
2015
Q1 | $44K | Hold |
104
| – | – | ﹤0.01% | 215 |
|
|
2014
Q4 | $35K | Hold |
104
| – | – | ﹤0.01% | 263 |
|
|
2014
Q3 | $34K | Hold |
104
| – | – | ﹤0.01% | 276 |
|
|
2014
Q2 | $33K | Sell |
104
-25
| -19% | -$7.52K | ﹤0.01% | 268 |
|
|
2014
Q1 | $39K | Sell |
129
-35
| -21% | -$11.1K | ﹤0.01% | 235 |
|
|
2013
Q4 | $46K | Hold |
164
| – | – | ﹤0.01% | 221 |
|
|
2013
Q3 | $39K | Hold |
164
| – | – | ﹤0.01% | 233 |
|
|
2013
Q2 | $35K | Buy |
+164
| New | +$35K | ﹤0.01% | 239 |
|
Other funds holding BIIB
Barrett Asset Management's BIIB Position: Q1 2022 in Review
Barrett Asset Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 185 shares — an estimated $44K sold.
Barrett Asset Management first reported a position in BIIB in Q2 2013 and held it in 35 quarters. The position peaked at $260K in Q2 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- Barrett Asset Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
- Barrett Asset Management sold 185 Biogen shares in Q1 2022, an estimated $44K.
- Barrett Asset Management first reported a position in Biogen in Q2 2013 and held it in 35 quarters.
- Barrett Asset Management's Biogen position peaked at $260K in Q2 2021.
- 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.